Copyright Reports & Markets. All rights reserved.

Global Diagnostic Radiopharmaceuticals & Contrast Media Market Research Report 2021

Request for Sample of this report
Buy now

1 Diagnostic Radiopharmaceuticals & Contrast Media Market Overview

  • 1.1 Product Overview and Scope of Diagnostic Radiopharmaceuticals & Contrast Media
  • 1.2 Diagnostic Radiopharmaceuticals & Contrast Media Segment by Type
    • 1.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Radiopharmaceuticals
    • 1.2.3 Contrast Media
  • 1.3 Diagnostic Radiopharmaceuticals & Contrast Media Segment by Application
    • 1.3.1 Diagnostic Radiopharmaceuticals & Contrast Media Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospital
    • 1.3.3 Clinic
    • 1.3.4 Other
  • 1.4 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size Estimates and Forecasts
    • 1.4.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue 2016-2027
    • 1.4.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales 2016-2027
    • 1.4.3 Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Region: 2016 Versus 2021 Versus 2027

2 Diagnostic Radiopharmaceuticals & Contrast Media Market Competition by Manufacturers

  • 2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Diagnostic Radiopharmaceuticals & Contrast Media Manufacturing Sites, Area Served, Product Type
  • 2.5 Diagnostic Radiopharmaceuticals & Contrast Media Market Competitive Situation and Trends
    • 2.5.1 Diagnostic Radiopharmaceuticals & Contrast Media Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Diagnostic Radiopharmaceuticals & Contrast Media Players Market Share by Revenue
    • 2.5.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Diagnostic Radiopharmaceuticals & Contrast Media Retrospective Market Scenario by Region

  • 3.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures by Country
    • 3.3.1 North America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country
    • 3.3.2 North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures by Country
    • 3.4.1 Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country
    • 3.4.2 Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region
    • 3.5.2 Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures by Country
    • 3.6.1 Latin America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country
    • 3.6.2 Latin America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country
    • 3.7.2 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Diagnostic Radiopharmaceuticals & Contrast Media Historic Market Analysis by Type

  • 4.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type (2016-2021)
  • 4.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Type (2016-2021)
  • 4.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Price by Type (2016-2021)

5 Global Diagnostic Radiopharmaceuticals & Contrast Media Historic Market Analysis by Application

  • 5.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application (2016-2021)
  • 5.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Application (2016-2021)
  • 5.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Amag Pharmaceuticals
    • 6.1.1 Amag Pharmaceuticals Corporation Information
    • 6.1.2 Amag Pharmaceuticals Description and Business Overview
    • 6.1.3 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Amag Pharmaceuticals Product Portfolio
    • 6.1.5 Amag Pharmaceuticals Recent Developments/Updates
  • 6.2 Bayer Healthcare
    • 6.2.1 Bayer Healthcare Corporation Information
    • 6.2.2 Bayer Healthcare Description and Business Overview
    • 6.2.3 Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Bayer Healthcare Product Portfolio
    • 6.2.5 Bayer Healthcare Recent Developments/Updates
  • 6.3 Bracco Imaging
    • 6.3.1 Bracco Imaging Corporation Information
    • 6.3.2 Bracco Imaging Description and Business Overview
    • 6.3.3 Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Bracco Imaging Product Portfolio
    • 6.3.5 Bracco Imaging Recent Developments/Updates
  • 6.4 Daiichi Sankyo
    • 6.4.1 Daiichi Sankyo Corporation Information
    • 6.4.2 Daiichi Sankyo Description and Business Overview
    • 6.4.3 Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Daiichi Sankyo Product Portfolio
    • 6.4.5 Daiichi Sankyo Recent Developments/Updates
  • 6.5 GE Healthcare
    • 6.5.1 GE Healthcare Corporation Information
    • 6.5.2 GE Healthcare Description and Business Overview
    • 6.5.3 GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 GE Healthcare Product Portfolio
    • 6.5.5 GE Healthcare Recent Developments/Updates
  • 6.6 Guerbet
    • 6.6.1 Guerbet Corporation Information
    • 6.6.2 Guerbet Description and Business Overview
    • 6.6.3 Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Guerbet Product Portfolio
    • 6.6.5 Guerbet Recent Developments/Updates
  • 6.7 Lantheus
    • 6.6.1 Lantheus Corporation Information
    • 6.6.2 Lantheus Description and Business Overview
    • 6.6.3 Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Lantheus Product Portfolio
    • 6.7.5 Lantheus Recent Developments/Updates
  • 6.8 Mallinckrodt
    • 6.8.1 Mallinckrodt Corporation Information
    • 6.8.2 Mallinckrodt Description and Business Overview
    • 6.8.3 Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Mallinckrodt Product Portfolio
    • 6.8.5 Mallinckrodt Recent Developments/Updates
  • 6.9 Medtronic
    • 6.9.1 Medtronic Corporation Information
    • 6.9.2 Medtronic Description and Business Overview
    • 6.9.3 Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Medtronic Product Portfolio
    • 6.9.5 Medtronic Recent Developments/Updates
  • 6.10 Nordion
    • 6.10.1 Nordion Corporation Information
    • 6.10.2 Nordion Description and Business Overview
    • 6.10.3 Nordion Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Nordion Product Portfolio
    • 6.10.5 Nordion Recent Developments/Updates

7 Diagnostic Radiopharmaceuticals & Contrast Media Manufacturing Cost Analysis

  • 7.1 Diagnostic Radiopharmaceuticals & Contrast Media Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Diagnostic Radiopharmaceuticals & Contrast Media
  • 7.4 Diagnostic Radiopharmaceuticals & Contrast Media Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Diagnostic Radiopharmaceuticals & Contrast Media Distributors List
  • 8.3 Diagnostic Radiopharmaceuticals & Contrast Media Customers

9 Diagnostic Radiopharmaceuticals & Contrast Media Market Dynamics

  • 9.1 Diagnostic Radiopharmaceuticals & Contrast Media Industry Trends
  • 9.2 Diagnostic Radiopharmaceuticals & Contrast Media Growth Drivers
  • 9.3 Diagnostic Radiopharmaceuticals & Contrast Media Market Challenges
  • 9.4 Diagnostic Radiopharmaceuticals & Contrast Media Market Restraints

10 Global Market Forecast

  • 10.1 Diagnostic Radiopharmaceuticals & Contrast Media Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Diagnostic Radiopharmaceuticals & Contrast Media by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Diagnostic Radiopharmaceuticals & Contrast Media by Type (2022-2027)
  • 10.2 Diagnostic Radiopharmaceuticals & Contrast Media Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Diagnostic Radiopharmaceuticals & Contrast Media by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Diagnostic Radiopharmaceuticals & Contrast Media by Application (2022-2027)
  • 10.3 Diagnostic Radiopharmaceuticals & Contrast Media Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Diagnostic Radiopharmaceuticals & Contrast Media by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Diagnostic Radiopharmaceuticals & Contrast Media by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Radiopharmaceuticals
    Contrast Media

    Segment by Application
    Hospital
    Clinic
    Other

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Amag Pharmaceuticals
    Bayer Healthcare
    Bracco Imaging
    Daiichi Sankyo
    GE Healthcare
    Guerbet
    Lantheus
    Mallinckrodt
    Medtronic
    Nordion

    Buy now